Human medicines European Public Assessment Report (EPAR): BeneFIX, nonacog alfa, Revision: 24, Authorised
Related Biotechnology, Pharmaceutical and Healthcare News
- Human medicines European Public Assessment Report (EPAR): BeneFIX, nonacog alfa, Revision: 26, Authorised
- Human medicines European Public Assessment Report (EPAR): Vpriv, velaglucerase alfa, Revision: 4, Authorised
- Human medicines European Public Assessment Report (EPAR): Opgenra, eptotermin alfa, Revision: 6, Authorised
- Human medicines European Public Assessment Report (EPAR): Ruconest, conestat alfa, Revision: 2, Authorised
- Human medicines European Public Assessment Report (EPAR): IntronA, interferon alfa-2b, Revision: 21, Authorised
Original Article: Human medicines European Public Assessment Report (EPAR): BeneFIX, nonacog alfa, Revision: 24, Authorised
NEXT ARTICLE
More From BioPortfolio on "Human medicines European Public Assessment Report (EPAR): BeneFIX, nonacog alfa, Revision: 24, Authorised"
Search BioPortfolio: